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ABSTRACT 
Objective: The main objective is to study the prevalence of acute cardiac and renal complications in poorly controlled diabetics and role of clinical 
pharmacist in modifying disease outcome by patient counselling in patients attending general medicine department.  
Methods: It is a non-experimental prospective observational study done for 6 months. Patients admitted with acute cardiac and renal complications 
are included in the study. Patient’s knowledge on the disease was assessed at baseline using a structured KAP questionnaire and then counselled. At 
baseline and follow-up FBG and RBG levels were recorded.  
Results: A total of 511 patients were observed. Prevalence of acute renal complications was found to be 9.7% (n=50) and acute cardiac 
complications were found to be 2.9% (n=15). The prevalence of both acute cardiac and renal complications was found to be 0.97% (n=5). The 
knowledge of the patients on disease, complications, diet and lifestyle modifications was found to be increased which lead to significant 
improvement in FBG at baseline and follow-up with a mean of differences of-20.72 and with SD of differences 11.22; p value<0.0001 and for RBG at 
baseline and follow-up with mean of differences-25.86 and with SD of differences 20.19; p value<0.0001.  
Conclusion: Uncontrolled diabetes for the first few years can cause acute cardiac and renal complications which are life threatening. Comparison of 
blood glucose at presenting and follow-up in association with education and counselling led to betterment of disease, outcome. 
Keywords: Prevalence, Diabetes, Complications, Clinical pharmacist, Questionnaire, Outcome. 
 
INTRODUCTION 
Diabetes mellitus is a metabolic disorder of multiple etiology 
characterized by chronic hyperglycaemia with disturbances of 
carbohydrate, fat and protein metabolism resulting from defects in 
insulin secretion, insulin action, or both. The effects of diabetes 
mellitus include long–term damage, dysfunction and failure of 
various organs [1]. The prevalence of diabetes is rapidly increasing 
throughout the world and particularly in developing countries like 
India. At present 382 million people have diabetes worldwide; by 
2035 this will rise to 592 million. In South- East Asian region 72.1 
million people have diabetes, 65.1 million of whom live in India and 
is estimated to be 109 million by 2035 [2, 3]. 
Type-2 DM often has a long asymptomatic period of hyperglycaemia, so 
many individuals with type-2 DM have complications at the time of 
diagnosis. It is demonstrated that a reduction in chronic hyperglycaemia 
can prevent or delay the occurrence of these complications [4, 5].  
The mode of developing risk for a wide range of cardiovascular diseases 
(CVD) in diabetics is twice the risk of non-diabetics. The increase in 
cardiovascular morbidity and mortality rates appears to relate to the 
synergism of hyperglycemia with other cardiovascular risk factors. The 
American Heart Association has designated DM as a "CHD risk 
equivalent." Type 2 diabetes patients without a prior MI have a similar 
risk for coronary artery–related events as non-diabetic individuals who 
have had a prior MI [6-8]. Diabetes is one of the common causes of end 
stage renal disease. Almost one, in three people with Type 2 diabetes 
develops overt kidney disease [6, 7]. The pathogenesis of diabetic 
nephropathy is related to chronic hyperglycemia [4, 9, 10]. 
The appropriate control of diabetes can be achieved not only by the 
use of pharmacological therapy but also by scientific counselling by 
a clinical pharmacist on the importance of medication adherence, 
awareness of long-term complications, regular blood glucose 
monitoring, life style changes including dietary modifications, 
smoking cessation, alcohol abstinence and regular exercise. The 
disease outcome can be improved and patient lead better quality of 
life by preventing or delaying the long term complications of the 
disease [11-17]. 
The main objective of the present study was to determine the 
prevalence of acute cardiac and renal complications which are 
chronic complications of diabetes and are presented acutely due to 
poorly controlled diabetes. Also the role of the clinical pharmacist in 
modifying the disease outcome by counselling the patient on various 
aspects of the disease, importance of medication, adherence and 
lifestyle modifications is studied. 
MATERIALS AND METHODS 
A non-experimental prospective observational study was conducted 
over a period 6 months from April to September of 2014 in the 
department of general medicine, Government General Hospital-a 
tertiary care hospital, in Guntur, Andhra Pradesh. Ethical approval 
was obtained from the institution before the initiation of the study. 
Patient was informed about the purpose of the study and written 
consent was taken prior to their participation in the study. Patient 
consent form was prepared in the vernacular language, Telugu. 
Paired t test was the statistical method employed to determine the 
significant difference between baseline and follow-up data. Type-1 
and type-2 diabetic patients attending general medicine ward over 
the age of 18 and with a basal blood glucose level of>160 mg/dl 
diagnosed with acute renal or cardiac complication or both were 
included in the study. Critically ill patients who cannot participate in 
the study, smokers and patients with connective tissue disorders 
diagnosed earlier were excluded from the study. 
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Both inpatients and outpatients were screened for the total number 
of diabetics. Patients diagnosed and admitted with acute renal or 
cardiac complications by the physician were included. Required data 
of the patient was collected from the patient case sheet. Family 
history of the patient, duration of diabetes, medication history, food 
and life style followed, other diabetic complications, laboratory 
investigations were recorded. The baseline knowledge of the 
patients included in the study was determined using a structured 
questionnaire on knowledge, attitude and practice (KAP) of diabetes 
which was done under the guidance of the physician in both 
vernacular (Telugu) and English language. The answers were 
recorded and the patient is counselled on the disease, complications, 
importance of regular blood glucose monitoring, diet, life style 
modifications and medication adherence. The fasting and random 
blood glucose levels of the patients are noted at the time of 
discharge. Patients were reviewed after 3 months for follow up. 
Patients with outcome of death were excluded. The patients were 
asked to answer the questionnaire again during follow-up and their 
fasting and random blood glucose levels were recorded. 
RESULTS 
A total of 511 diabetic patients were observed over the period of 6 
months. Out of the total, 56% (n=282) were women. Among the total 
diabetics, 18% had a family history of diabetes. The age of onset of 
diabetes was found to be 33% (n=167) in 51-60 years age group, 
followed by 31% (n=157) in 41-50 years age group, 15% (n=78) in 
61-70 years age group and 14% (n=72) in 31-40 years age group.  
A majority of 53% (n=270) of patients were with duration of 
diabetes ≤ 5 years, followed by 25% (n=129) with 6-10 years of 
duration, 10% (n=53) patients with DE novo diabetes, 7% (n=36) 
with 11-15 years of diabetes duration and only 5% (n=23) patients 
with ˃15 years in duration. 92% (472) of the diabetic patients were 
on treatment among which 74% (n=377) were using oral 
hypoglycemic agents, 11% (n=58) were using insulin preparations 
and 7% (n=37) of the patients were using both oral hypoglycemic 
agents and insulin preparations for the management of diabetes. 
56% (n=285) were presented with various complications of the 
disease and 44% (n=226) did not show the presence of any diabetic 
complications. Neuropathy is the prominent microvascular 
complication with 25% (n=128), followed by Retinopathy in 22% 
(n=112) and Nephropathy in 18% (n=93).  
Among the macro vascular complications observed, coronary 
complications were prominent 22% (n=113), followed by vascular 
complications in 7% (n=36) of diabetic patients. Further information 
is given in table 1. 
 
Table 1: Demographic and disease related details of patients 
 Variables Total number of patients N=511 n (%) 
Sex wise distribution  Male 219 (44) 
 Female 282 (56) 
Family history Maternal history 51 (10) 
 Paternal history 26 (5) 
 Both maternal and Paternal history 13 (2.5) 
 No history 421 (82) 
Age of onset of diabetes 18-30 years 24 (5) 
 31-40 years 72 (14) 
 41-50 years 157 (31) 
 51-60 years 167 (33) 
 61-70 years 78 (15) 
 >70 years 13 (2) 
Duration of DM DE novo 53 (10) 
 <5 years 270 (53) 
 6-10 years 129 (25) 
 11-15 years 36 (7) 
 >15 years 23 (5) 
Medication history Using OHA 377 (74) 
 Using insulin 58 (11) 
 Using both OHA and insulin 37 (7) 
 Not on treatment 39 (8) 
Complications Renal complications 93 (18) 
 Neuropathy 128 (25) 
 Vascular complications 36 (7) 
 Retinopathy 112 (22) 
 Coronary  113 (22) 
 No complications 226 (44) 
Distribution of Acute complications Renal  50 (9.7) 
 Cardiac 15 (2.9) 
 Both renal and cardiac 5 (0.97) 
 
A total of 30% (n=155) of patients were admitted with renal and 
cardiac complications among which 13.6% (n=70) of patients were 
admitted with acute condition. Patients with acute renal complications 
were9.7% (n=50), acute cardiac complications were2.9% (n=15) and 
with both acute cardiac and renal complications were0.97% (n=5). 
The data is graphically represented in fig. 1. 
Onset of renal and cardiac complications was found to be 36% 
(n=56) in patients with 1-5 years of duration of diabetes, followed 
by 31.6% (n=49) in patients with 6-10 years of duration, then 10.6% 
(n=16) with 11-15 years of duration of diabetes. 71% (n=40) of the 
subjects in the duration of 1-5 years of diabetes were not on regular 
medication. Further detail on duration of diabetes for development 
of renal and cardiac complications is given in fig. 2. 
The number of men and women with acute complications was 
equally distributed. Further information on mean ages of subjects 
with acute complications is given in table 2. 
Total number of subjects with death as the outcome is 12 (17.4%) 
among them 66% (8) were men. 91.6% of subjects succumbed to 
death were with acute renal complication and only 8.4% with acute 
cardiac complications. Details on mean ages of these subjects are 
furnished in table 3. 
Knowledge 
At baseline approach 87% of the subjects do not know what diabetes 
mellitus is, which was decreased to 23% after the counselling, 58% think 
that diabetes can be cured and at follow-up only 9% did not know. 72% 
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of the subjects were not aware of the normal blood glucose levels but at 
follow-up 84% were able to tell the normal value. Also there was 
significant improvement in the knowledge of patients regarding the 
symptoms of the disease, causes of hypoglycaemia, its symptoms and 
management. 97% of the subjects have no idea that diabetes could cause 
various complications which was drastically decreased at the time of 
follow-up to 20%. Also knowledge on foods to be taken, avoided and life 
style modifications was found to be improved. Further information 
regarding the subject’s knowledge on disease is furnished in table 4. 
 
 
Fig. 1: Distribution of acute renal and cardiac complications 
 
 
Fig. 2: Duration of diabetes for development of renal and 
cardiac complications 
Table 2: Mean ages of subjects with acute complications 
 No. of Men (35) 
(Mean age) 
No. of women (35) Mean 
age 
Cardiac 7 (55.4±5.07) 8 (59.9±8.8) 
Renal 26 (56.4±11.9) 24 (55.7±10.8) 
Both  2 (59±15.5) 3 (58.6±15.5) 
 
Subjects with acute renal and cardiac complications (70) were 
evaluated for their knowledge, attitude and practice towards 
diabetes at baseline and during the follow up. 
12 subjects were excluded from evaluation due to the outcome of 
death. 58 subjects were reviewed after 3 months. It was 
observed that there is a significant improvement in the 
knowledge of the subjects on the disease, complications and 
normal blood glucose levels. 
 
Table 3: Mean ages of subjects with outcome death due to acute 
complications 
 No. of Men  
(mean age) 
 No. of women  
(mean age) 
Cardiac - 1 (75) 
Renal 8 (57.25±10.7) 3 (61±3.6) 
 
Attitude and Practice 
Most of the patients were not sure if they could eat with or without 
food restrictions if their blood glucose levels are under control, but 
after counselling at the time of follow-up 77% know they have to 
follow food restrictions. Also 82% of subjects think they can 
discontinue medication if they have controlled blood glucose levels 
which was decreased to 16% at follow-up.  
The practice of patients regarding their medication taking behaviour 
was also improved from baseline to follow-up. Further details are 
given in table 4. The response of the patients to knowledge, attitude 
and practice related questions at baseline and follow-up is given in 
table 4. 
 
Table 4: Response of the subjects to KAP questionnaire at baseline and follow-up 
Knowledge  Baseline Follow-up 
No. of patients(58) No. of patients  
Aware n (%) Not aware (%) Aware (%) Not aware (%) 
Do you know what Diabetes Mellitus is? 8 (13) 50 (87) 45 (77) 13 (23) 
Do you think that diabetes is a life lasting disease and cannot be cured? 24 (42) 34 (58) 53 (91) 5 (9) 
Do you know what the normal blood glucose level is? 16 (28) 42 (72) 49 (84) 9 (16) 
Can you recognize the symptom(s) of diabetes? 10 (17) 48 (83) 54 (94)  4 (6) 
Do you know that skipping meals after taking  
medication can cause hypoglycemia? 
17 (29) 41 (71) 47 (81) 11 (19) 
Can you recognize hypoglycemic symptoms? 3 (5) 55 (95) 51 (87) 7 (13) 
Do you know how to manage hypoglycemic symptoms? 3 (5) 55 (95) 49 (84) 11 (16) 
Do you know that diabetes can cause complications? 2 (3) 56 (97) 48 (80) 12 (20) 
Do you know that diabetic patients should follow a diet modification? 22 (37) 36 (63) 49 (85) 9 (15) 
Do you know what food should be avoided? 17 (29)  41 (71) 43 (74) 15 (26) 
Do you know lifestyle modifications can control blood glucose 7 (13) 51 (87) 37 (63) 21 (37) 
Attitude  
Do you think that a diabetic person with a normal blood glucose level 















When your blood glucose levels are under control, do you think you can 









Practice Yes No Yes No 
Do you monitor your blood glucose level at home? 
 
8 (14) 50 (86) 11 (19) 47 (81) 
Are you following a controlled and planned diet?  
 
16 (27) 42 (73) 52 (90) 6 (10) 
When you travel or leave home, do you sometimes forget to carry your 35 (60) 23(40) 48 (82) 10 (18) 
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How often do you get your blood 







































The mean FBG level in 58 patients at baseline i.e. at time of 
discharge is 140.03±18.59 and at follow-up is 119.31±13.19 and 
mean of differences is-20.72 with SD of differences 11.22; p 
value<0.0001. The mean RBG level at baseline i.e. at time of 
discharge is 191.43±29 and at follow-up is 165.56±16.81 and mean 
of differences is-25.86 with SD of differences 20.19; p value<0.0001. 
The data is graphically represented in fig. 2 and 3 respectively. 
 
 
Fig. 3: Paired t test data of FBG levels at baseline and follow-up 
 
 
Fig. 4: Paired t test data of RBG levels at baseline and follow-up 
 
DISCUSSION 
The prevalence of diabetes is growing throughout the world, mostly 
in developing countries like India, recording 65.1 million diabetics 
which are highest among South East Asian countries [2]. Initially due 
to urbanisation, the prevalence of diabetes was 4-6 times higher in 
the urban population than in rural areas from 1971-2001 [18, 19]. 
Majority of the population in India resides in rural area, it is found 
that ratio of unknown-to-known diabetes is 3:1 in rural areas 
(compared to 1:1 in urban areas) which shows that there is 
decreased awareness on chronic diseases like diabetes mellitus. As 
the majority of cases go undiagnosed many of the patients present 
with complications at the time of diagnosis [20, 21]. 
In the present study, prevalence of diabetes was found to be more in 
females 56% (n=282) than in males 44% (n=219) which are similar 
to that of the literature [4, 8]. Also diabetes was found to be high-
33% (n=167) in people aged 51-60 years of age with a mean age of 
57.1 years followed by 31% (n=157) in the age group of 41-50 years 
with a mean age of 47 years. The maximum number of people with 
diabetes was observed between 41-60 years of age. The same age 
group was seen in other studies [22, 23]. 
In a study conducted in India showed that prevalence of 
complications in 3010 type-2 diabetic patients was Retinopathy 
23.7%, Nephropathy 5.5%, Peri-neuropathy 27.5%, Cardiovascular 
disease 11.4%, Hypertension 38%, Peripheral vascular disease 4.0, 
Cerebrovascular accidents 0.9%[18,20]. In our study, we found that 
among the total diabetics, 56% (n=285) were presented with 
various complications of the disease and 44% (n=226) did not show 
the presence of any diabetic complications. Neuropathy is the 
prominent micro vascular complication with 25% (n=128), followed 
by retinopathy in 22% (n=113) and nephropathy in 18% (n=93). 
Among the macro vascular complications observed, coronary 
complications were prominent 22% (n=112), followed by vascular 
complications in 7% (n=36) of diabetic patients. This shows that 
neuropathy is the commonest diabetic complication observed 
followed by retinopathy. 
In our study, we found that a total of 30% (n=155) of patients were 
admitted with renal and cardiac complications among which 13.6% 
(n=70) of patients were admitted with acute condition. Onset of 
renal and cardiac complications was seen mostly in patients 
between 1-5 years (mean duration 3.03 years) after the diagnosis of 
diabetes i.e. 36% (n=56) which is due to lack of medication 
adherence and drug use, lack of dietary and lifestyle modifications. 
Followed by 31.6% (n=49) in between 6-10 years (mean duration 8 
years). 71% (n=40) of the subjects in the duration of 1-5 years of 
diabetes were not on regular medication and only 29% (n=16) are 
taking their medication properly. 
Many studies conducted stated the prevalence of chronic 
complications of diabetes but not the prevalence of acute onset of 
chronic complications. In the present study, the prevalence of acute 
renal complications was estimated and found to be 9.7% (n=50) and 
acute cardiac complications were found to be 2.9% (n=15). The 
prevalence of both acute cardiac and renal complications was found 
to be 0.97% (n=5). It was observed that the acute renal and cardiac 
complications were equally prevalent in both males (35) and 
females (35). Mean age of males with acute renal complications was 
found to be 56.4±11.9 and in females 55.7±10.8. Mean age of males 
with acute cardiac complication was found to be less 55.4±5.07 
when compared to females 59.9±8.8. Mean ages of males and 
females with both acute cardiac and renal complications were found 
to be 59±15.5 and 58.6±15.5 respectively.  
In this study at baseline it was found that patient’s knowledge on 
disease, its complications, dietary modifications, importance of 
medication adherence and life style modifications, is poor which can 
be the main cause for the development of complications in the 1st 
decade of disease. After counselling, at the time of follow-up there 
was a significant improvement of knowledge on maintenance of 
blood glucose levels, foods to be taken and avoided, importance of 
medication adherence, identification and management of 
hypoglycaemia. The significant improvement in FBG levels at 
baseline and follow-up with a mean of differences of-20.72 and with 
SD of differences 11.22; p value<0.0001 and for RBG at baseline and 
follow-up with mean of differences-25.86 and with SD of differences 
20.19; p value<0.0001. 
Several other studies also concluded that there is an improvement in 
knowledge of the disease lead to better glycaemic control and 
clinical outcome [16, 17, 22, 25]. Hinchageri et. al, showed that there 
was an improvement in patient’s lab parameters such as HbA1c, FBS, 
PPBS, blood pressure due to increase in their knowledge on diabetes 
[17]. Ramesh Adepu et. al’s study also concluded that a significant 
(p<0.05) improvement in KAP, mean scores of regimen, was 
observed in all test group patients after a pharmacist provided 
structured education to the patient [24]. 
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This study shows that due to lack of knowledge on disease, there is 
an early onset of chronic complications of diabetes which increases 
morbidity and mortality, but a proper counselling by a pharmacist 
can improve knowledge on disease thereby preventing the early 
onset and recurrence of complications. 
CONCLUSION 
From our study, we conclude that uncontrolled diabetes for the first 
few years can cause acute cardiac and renal complications where the 
prevalence was 13.6%, which are life threatening and poorly 
controlled diabetes can cause long term cardiac and renal 
complications albeit with mortality rate. Comparison of blood 
glucose at presenting and follow-up in association with education 
and counselling by a clinical pharmacist betterment of disease, 
outcome, decreased hospitalization and improved patient lifestyle. 
This study was conducted in a government teaching general hospital 
and needs to be carried out on large scale to extrapolate the results 
to general populations. 
ABBREVIATION 
CHD-Congestive Heart Disease, CVD-Cardiovascular Disease, DM-
Diabetes Mellitus, FBG-Fasting Blood Glucose, KAP-Knowledge 
Attitude Practice, MI-Myocardial Infarction, OHA-Oral Hypo 
glycaemic Agents, RBG-Random Blood Glucose, SD-Standard 
Deviation.  
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